Research ArticleExperimental Studies

Curcumin and Epigallocatechin Gallate Inhibit the Cancer Stem Cell Phenotype via Down-regulation of STAT3–NFκB Signaling

SEYUNG S. CHUNG and JAYDUTT V. VADGAMA
Anticancer Research January 2015, 35 (1) 39-46;

Article Information

vol. 35 no. 1 39-46
PubMed 
25550533
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received September 26, 2014
  • Revision received October 22, 2014
  • Accepted October 27, 2014
  • Published online December 30, 2014.
Copyright & Usage 
Copyright© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. SEYUNG S. CHUNG1⇑ and
  2. JAYDUTT V. VADGAMA1,2,3
  1. 1Division of Cancer Research and Training, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA, U.S.A.
  2. 2Jonson Comprehensive Cancer Center, Los Angeles, CA, U.S.A.
  3. 3UCLA Department of Medicine, Los Angeles, CA, U.S.A.
  1. Correspondence to: Dr. Seyung Chung, Division of Cancer Research and Training, Charles R. Drew University of Medicine and Science, 1731 East 120th Street, Los Angeles, CA 90059, U.S.A. Tel: +1 3235634853, Fax: +1 3235634859, e-mail: seyungchung{at}cdrewu.edu
View Full Text

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Curcumin and Epigallocatechin Gallate Inhibit the Cancer Stem Cell Phenotype via Down-regulation of STAT3–NFκB Signaling
SEYUNG S. CHUNG, JAYDUTT V. VADGAMA
Anticancer Research Jan 2015, 35 (1) 39-46;
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords